{"doc_id": "PMID-10491412.txt", "sent_id": "", "tokens": ["Renal", "cell", "carcinoma", "-", "derived", "gangliosides", "suppress", "nuclear", "factor-kappaB", "activation", "in", "T", "cells", "."], "sentence": "Renal cell carcinoma - derived gangliosides suppress nuclear factor-kappaB activation in T cells .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10491412.txt", "sent_id": "", "tokens": ["Activation", "of", "the", "transcription", "factor", "nuclear", "factor-kappaB", "(", "NFkappaB", ")", "is", "impaired", "in", "T", "cells", "from", "patients", "with", "renal", "cell", "carcinomas", "(", "RCCs", ")", "."], "sentence": "Activation of the transcription factor nuclear factor-kappaB ( NFkappaB ) is impaired in T cells from patients with renal cell carcinomas ( RCCs ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10491412.txt", "sent_id": "S3", "tokens": ["In", "circulating", "T", "cells", "from", "a", "subset", "of", "patients", "with", "RCCs", ",", "the", "suppression", "of", "NFkappaB", "binding", "activity", "is", "downstream", "from", "the", "stimulus", "-", "induced", "degradation", "of", "the", "cytoplasmic", "factor", "IkappaBalpha", "."], "sentence": "In circulating T cells from a subset of patients with RCCs , the suppression of NFkappaB binding activity is downstream from the stimulus - induced degradation of the cytoplasmic factor IkappaBalpha .", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 24, "end": 24}, "arguments": [{"entity_id": "T6", "text": "degradation", "role": "Theme"}]}, {"id": "E2", "event_type": "Protein_catabolism", "trigger": {"text": "degradation", "start": 25, "end": 25}, "arguments": [{"entity_id": "T1", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "IkappaBalpha", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T5", "text": "induced", "entity_type": "Positive_regulation", "start": 24, "end": 24}, {"id": "T6", "text": "degradation", "entity_type": "Protein_catabolism", "start": 25, "end": 25}]}
{"doc_id": "PMID-10491412.txt", "sent_id": "S4", "tokens": ["Tumor", "-", "derived", "soluble", "products", "from", "cultured", "RCC", "explants", "inhibit", "NFkappaB", "activity", "in", "T", "cells", "from", "healthy", "volunteers", ",", "despite", "a", "normal", "level", "of", "stimulus", "-", "induced", "IkappaBalpha", "degradation", "in", "these", "cells", "."], "sentence": "Tumor - derived soluble products from cultured RCC explants inhibit NFkappaB activity in T cells from healthy volunteers , despite a normal level of stimulus - induced IkappaBalpha degradation in these cells .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "normal level", "start": 21, "end": 22}, "arguments": [{"entity_id": "T9", "text": "degradation", "role": "Theme"}]}, {"id": "E4", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 26, "end": 26}, "arguments": [{"entity_id": "T9", "text": "degradation", "role": "Theme"}]}, {"id": "E5", "event_type": "Protein_catabolism", "trigger": {"text": "degradation", "start": 28, "end": 28}, "arguments": [{"entity_id": "T2", "text": "IkappaBalpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "IkappaBalpha", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T7", "text": "normal level", "entity_type": "Negative_regulation", "start": 21, "end": 22}, {"id": "T8", "text": "induced", "entity_type": "Positive_regulation", "start": 26, "end": 26}, {"id": "T9", "text": "degradation", "entity_type": "Protein_catabolism", "start": 28, "end": 28}]}
{"doc_id": "PMID-10491412.txt", "sent_id": "", "tokens": ["The", "inhibitory", "agent", "has", "several", "features", "characteristic", "of", "a", "ganglioside", ",", "including", "sensitivity", "to", "neuraminidase", "but", "not", "protease", "treatment", ";", "hydrophobicity", ";", "and", "molecular", "weight", "less", "than", "3", "kDa", "."], "sentence": "The inhibitory agent has several features characteristic of a ganglioside , including sensitivity to neuraminidase but not protease treatment ; hydrophobicity ; and molecular weight less than 3 kDa .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10491412.txt", "sent_id": "", "tokens": ["Indeed", ",", "we", "detected", "gangliosides", "in", "supernatants", "from", "RCC", "explants", "and", "not", "from", "adjacent", "normal", "kidney", "tissue", "."], "sentence": "Indeed , we detected gangliosides in supernatants from RCC explants and not from adjacent normal kidney tissue .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-10491412.txt", "sent_id": "S7", "tokens": ["Gangliosides", "prepared", "from", "RCC", "supernatants", ",", "as", "well", "as", "the", "purified", "bovine", "gangliosides", "G", "(", "m1", ")", "and", "G", "(", "d1a", ")", ",", "suppressed", "NFkappaB", "binding", "activity", "in", "T", "cells", "and", "reduced", "expression", "of", "the", "cytokines", "IL-2", "and", "IFN-gamma", "."], "sentence": "Gangliosides prepared from RCC supernatants , as well as the purified bovine gangliosides G ( m1 ) and G ( d1a ) , suppressed NFkappaB binding activity in T cells and reduced expression of the cytokines IL-2 and IFN-gamma .", "event_mentions": [{"id": "E6", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 31, "end": 31}, "arguments": [{"entity_id": "T11", "text": "expression", "role": "Theme"}]}, {"id": "E7", "event_type": "Negative_regulation", "trigger": {"text": "reduced", "start": 31, "end": 31}, "arguments": [{"entity_id": "T11", "text": "expression", "role": "Theme"}]}, {"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 32, "end": 32}, "arguments": [{"entity_id": "T4", "text": "IFN-gamma", "role": "Theme"}]}, {"id": "E9", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 32, "end": 32}, "arguments": [{"entity_id": "T3", "text": "IL-2", "role": "Theme"}]}], "entity_mentions": [{"id": "T3", "text": "IL-2", "entity_type": "Protein", "start": 36, "end": 36}, {"id": "T4", "text": "IFN-gamma", "entity_type": "Protein", "start": 38, "end": 38}, {"id": "T10", "text": "reduced", "entity_type": "Negative_regulation", "start": 31, "end": 31}, {"id": "T11", "text": "expression", "entity_type": "Gene_expression", "start": 32, "end": 32}]}
{"doc_id": "PMID-10491412.txt", "sent_id": "", "tokens": ["Taken", "together", ",", "our", "findings", "suggest", "that", "tumor", "-", "derived", "gangliosides", "may", "blunt", "antitumor", "immune", "responses", "in", "patients", "with", "RCCs", "."], "sentence": "Taken together , our findings suggest that tumor - derived gangliosides may blunt antitumor immune responses in patients with RCCs .", "event_mentions": [], "entity_mentions": []}
